Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
- Status
- RECRUITING
- Phase
- PHASE3
Related studies linked through entity extraction aliases.